Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects

Journal of Medical Sciences

Volumn 10, Issue 1, 2010, Pages 1-11

  Higashino, Hideaki ^a,b   Tabuchi, M ^a   Yamagata, S ^a   Kurita, T ^a   Miya, H ^b   Mukai, H ^b   Miya, Y ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Higashi Yodogawa Hospital   (Japan)

Author keywords

Inflammatory diseases; Nitric oxide metabolites (NOx); Pathophysiology; Patients; Serum

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ACCURACY; ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHEMOLUMINESCENCE; CHRONIC INFLAMMATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEPATITIS B; HEPATITIS C; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INFLAMMATORY DISEASE; KIDNEY DISEASE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OSTEOPOROSIS; PATHOPHYSIOLOGY; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROIDITIS;

EID: 77954737991     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2010.1.11     Document Type: Article

References (52)

1. Agresti, A., 1992. A survey of exact inference for contegency tables. Stat. Sci., 7: 131-153.
2. Akarasereenont, P., T. Nuamchit, A. Thaworn, W. Leowattana, S. Chotewuttakorn and P. Khunawat, 2001. Serum nitric oxide levels in patients with coronary artery disease. J. Med. Assoc. Thai., 84: S730-S739.
3. Choi, J.W., 2003. Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin. Chim. Acta, 336: 83-87.
4. Chou, T.C., M.H. Yen, C.Y. Li and Y.A. Ding, 1998. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension, 31: 643-648.
5. Colin, I.M., P. Kopp, J. Zbaren, A. Haberli, W.E. Grizzle and J.L. Jameson, 1997. Expression of nitric oxide synthase III in human thyroid follicular cells: Evidence for increased expression in hyperthyroidism. Eur. J. Endocrinol., 136: 649-655.
6. Datta, P.K., S. Dhupar and E.A. Lianos, 2006. Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis. Nephrol. Dial. Transplant., 21: 51-57.
7. Duric, D., V. Jakovljevic, M. Stojkovic, A. Duric and B. Petrovic, 2003. Clinical assessment of major artery vasomotor endothelial function: Methodology and importance for evaluating aging as a cardiovascular risk factor. Med. Pregl., 56: 9-12.
8. Ekmekçi, H., I. Iler, H. Sönmez, C. Gürel, O. Ciftçi and T. Ulutin, 2006. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease. Thromb. Res., 117: 249-254.
9. Förstermann, U., E.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gath and H. Kleinert, 1994. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions. Hypertension, 23: 1121-1131.
10. Girden, E.R., 1992. ANOVA: Repeated Measures. In: Quantitative Applcations in the Social Sciences, Sage University Paper (Eds.). Sage Publications, Inc., CA., USA., pp: 1.
11. Higashino, H., H. Miya, H. Mukai and Y. Miya, 2006. The serum nitric oxide metabolite (NOx) concentrations of hypertensive patients at rest in relation to age, sex, blood pressure and complications with healthy controls. Clin. Exp. Pharmacol. Physiol., 34: 725-731.
12. Ikeda, I., T. Kasajima, S. Ishiyama, T. Shimojo and Y. Takeox et-al, 1997. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am. J. Gastroenterol., 92: 1339-1341.
13. Kamanaka, Y., A. Kawabata, H. Matsuya, C. Taga, F. Sekiguchi and N. Kawao, 2003. Effect of a potent iNOS inhibitor (ONO-1714) on acetaminophen-induced hepatotoxicity in the rats. Life Sci., 74: 793-802.
14. Kamiya, T., Y. Ohta, Y. Imai, T. Arisawa and H. Nakano, 2005. A critical role of gastric mucosal ascorbic acid in the progression of acute gastric mucosal lesions induced by compound 48/80 in rats. World J. Gastroenterol., 11: 1324-1332.
15. Kang, D.H., S.K. Park, I.K. Lee and R.J. Johnson, 2005. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol., 16: 3553-3562.
16. Kawashima, H., Y. Inage, M. Ogihara, Y. Kashiwagi and K. Takekuma et al., 2004. Serum and cerebrospinal fluid nitrite/nitrate levels in patients with rotavirus gastroenteritis induced convulsion. Life Sci., 74: 1397-1405.
17. Kayser, L., D. Francis and H. Broholm, 2000. Immunohistochemical localization of inducible and endothelial constitutive nitric oxide synthase in neoplastic and autoimmune thyroid disorders. APMIS., 108: 785-791.
18. Khosla, U.M., S. Zharikov, J.L. Finch, T. Nakagawa and C. Roncal et al., 2005. Hyperuricemia induces endothelial dysfunction. Kidney Int., 67: 1739-1742.
19. Konishi, Y., T. Morikawa, T. Yasu, K. Teramoto and N. Okada et al., 2004. Blunted response of the renin-angiotensin system and nitric oxide synthesis related to sodium sensitivity in immunoglobulin a nephropathy. Hypertens. Res., 27: 7-13.
20. Koroliczuk, A., D. Chibowski, J. Beltowski and G. Wojcicka, 2001. Selected markers of oxidative stress in rats with active Heymann nephritis. Med. Sci. Monit., 7: 369-376.
21. Kurita, A., T. Matsui, T. Ishizuka, B. Takase and K. Satomura, 2005. Significance of plasma nitric oxide/endothelial-1 ratio for prediction of coronary artery disease. Angiology, 56: 259-264.
22. Lluch, P., M.D. Mauricio, J.M. Vila, G. Segarra and P. Medina et al., 2006. Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp. Biol. Med. (Maywood), 231: 70-75.
23. Loukovaara, M.J., S. Loukovaara, P.J. Leinonen, K.A. Teramo and S.H. Andersson, 2005. Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur. J. Obstet. Gynencol. Reprod. Biol., 118: 160-165.
24. Mackenzie, I.M., A. Ekangaki, J.D. Young and C.S. Garrard, 1996. Effect of renal function on serum nitrogen oxide concentrations. Clin. Chem., 42: 440-444.
25. Matsubara, T., T. Ishibashi, T. Hori, K. Ozaki and T. Mezaki, et al., 2003. Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries. Mol. Cell Biochem., 249: 67-73.
26. Matsuda, H., K. Hayashi, K. Homma, K. Yoshioka and T. Kanda et al., 2003. Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Hypertens. Res., 26: 875-880.
27. McFarlane, S.I., R. Muniyappa, J.J. Shin, G. Bahtiyar and J.R. Sowers, 2004. Osteoporosis and cardiovascular disease: Brittle bones and boned arteries, is there a link? Endocrine, 23: 1-10.
28. Mihm, S., A. Fayyazi and G. Ramadori, 1997. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: Relation to hepatic viral load and liver injury. Hepatology, 26: 451-458.
29. Mizumoto, M., S. Arii, M. Furutani, T. Nakamura and S. Ishigami et al., 1997. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J. Sug. Res., 70: 124-133.
30. Moriyama, A., A. Tabaru, H. Unoki, S. Abe, T. Masumoto and M. Otsuki, 2000. Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma. Clin. Chim. Acta, 296: 181-191.
31. Moussa, Y.I., J.N. Plevris and P.C. Hayes, 2000. Plasma nitrites/nitrates in HCV infection and hepatocelluar carcinoma. Eur. J. Gastroenterol. Hepatol., 12: 159-163.
32. Nabhan, A.F., 2006. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: A pilot study. Hum. Reprod., 21: 1320-1324.
33. Ni, Z. and N.D. Vaziri, 2003. Downregulation of nitric oxide synthase in nephritic syndrome: Role of proteinuria. Biochim. Biophys. Acta, 1638: 129-137.
34. Node, K., M. Kitakaze, H. Kosaka, K. Komamura and T. Minamino et al., 1996. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation, 93: 356-364.
35. Oates, J.C., E.F. Christensen, C.M. Reilly, S.E. Self and G.S. Gilkeson, 1999. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity. Proc. Assoc. Am. Physicians, 111: 611-621.
36. Oekonomaki, E., G. Notas, I.A. Mouzas, V. Valatas, P. Skordilis, C. Xidakis and E.A. Kouroumalis, 2004. Binge drinking and nitric oxide metabolites in chronic liver disease. Alcohol Alcoholism, 39: 106-109.
37. Orlandi, A., A. Francesconi, M. Marcellini, A. Ferlosio and L.G. Spagnoli, 2004. Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit. Cardiovasc. Res., 64: 544-552.
38. Orús, J., M. Heras, M. Morales-Ruiz, A. Leivas and E. Roig et al., 2000. Nitric oxide synthase II mRNA expression in cardiac tissue of patients with heart failure undergoing cardiac transplantation. J. Heart Lung Transplant., 19: 139-144.
39. Ozden, S., S. Tatlipinar, N. Biçer, V. Yaylali, C. Yildirim, D. Ozbay and G. Güner, 2003. Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can. J. Ophthalmol., 38: 393-396.
40. Parasher, G., L. Frenklakh, D.R. Goodman, T. Siddiqui, J. Nandi and R.A. Levine, 2001. Nitric oxide inhibitors ameriolate indomethacin-induced enteropathy in rats. Dig. Dis. Sci., 46: 2536-2541.
41. Pennisi, P., M.A. D'Alcamo, C. Leonetti, A. Clementi and V.M. Cutuli et al., 2005. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model. J. Bone Miner. Metab., 23: 134-139.
42. Rees, D.C., J. Satsangi, P.L. Cornelissen, S.P. Travis, J. White and D.P. Jewell, 1995. Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis? Eur. J. Gastroenterol. Hepatol., 7: 227-230.
43. Sahin, G., H. Guler, M. Sezgin, N.A. Incel and G. Polat, 2006. The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: A preliminary report. Rheumatol. Int., 26: 805-809.
44. Szaleczky, E., L. Pronai, H. Nakazawa and Z. Tulassay, 2000. Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrate/nitrite levels and lower protection against oxygen free radicals. J. Clin. Gastroenterol., 30: 47-51.
45. Thuraisingham, R.C. and M.M. Yaqoob, 2003. Oxidative consumption of nitric oxide: A potential mediator of uremic vascular disease. Kidney Int., 84: S29-S32. Timoshenko, A.V., O.V. Maslakova, B. Werle, V.A. Bezmen, V.Y. Rebeko and K. Kayser, 2002. Presentation of NO-metabolites (nitrate/nitrite) in blood serum and pleural effusions from cancer patients with pleurisy. Cancer Lett., 182: 93-99.
46. Ukawa, H., H. Yamakuni, S. Kato and K. Takeuchi, 1998. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig. Dis. Sci., 43: 2003-2011.
47. Ungvari, Z., A. Csiszar and G. Kaley, 2004. Vascular inflammation in aging. Herz, 29: 733-740.
48. Van den Hove, M.F., M.S. Stoenoiu, K. Croizet, M. Couvreur, P.J. Courtoy, O. Devuyst and I.M. Colin, 2002. Nitric oxide is involved in interleukin-1-induced cytotoxicity in polarized human thyrocytes. J. Endocrinol., 173: 177-185.
49. Wang, Y.X. and R.M. Fitch, 2004. Vascular stiffness: Measurements, mechanisms and implications. Curr. Vasc. Pharmacol., 2: 379-384.
50. Yasuhiro, T., R.P. Korolkiewicz, S. Kato and K. Takeuchi, 1997. Role of nitric oxide in pathogenesis of serotonine-induced gastric lesions in rats. Pharmacol. Res., 36: 333-338.
51. ter Steege, J.C., L. Koster-Kamphuis, E.A. van Straaten, P.P. Forget and W.A. Buurman, 1998. Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic. Biol. Med., 25: 953-963.
52. ter Steege, J.C., M.W. van de Ven, P.P. Forget, P. Brouckaert and W.A. Buurman, 1998. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model. Cytokine, 10: 115-123